Your browser doesn't support javascript.
loading
Proposal of selective inhibitor for bacterial zinc metalloprotease: Molecular mechanics and ab initio molecular orbital calculations.
Imai, Kyohei; Saito, Ryosuke; Ezawa, Takuya; Sugiyama, Satoshi; Sylte, Ingebrigt; Kurita, Noriyuki.
Afiliação
  • Imai K; Department of Computer Science and Engineering, Toyohashi University of Technology, Toyohashi, 441-8580, Japan.
  • Saito R; Department of Computer Science and Engineering, Toyohashi University of Technology, Toyohashi, 441-8580, Japan.
  • Ezawa T; Department of Computer Science and Engineering, Toyohashi University of Technology, Toyohashi, 441-8580, Japan.
  • Sugiyama S; Department of Computer Science and Engineering, Toyohashi University of Technology, Toyohashi, 441-8580, Japan.
  • Sylte I; Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway.
  • Kurita N; Department of Computer Science and Engineering, Toyohashi University of Technology, Toyohashi, 441-8580, Japan. Electronic address: kurita@cs.tut.ac.jp.
J Mol Graph Model ; 110: 108047, 2022 01.
Article em En | MEDLINE | ID: mdl-34655919
ABSTRACT
The zinc metalloprotease pseudolysin (PLN) secreted from Pseudomonas aeruginosa degrades extracellular proteins to produce bacterial nutrition, and various types of PLN inhibitors have been developed to suppress the bacterial growth. However, as the structure of the ligand-binding pocket of PLN has large similarities to those of human matrix metalloproteinases (MMPs) and other human zinc metalloprotease, there is a risk that PLN inhibitors also inhibit human zinc proteases. In this study, we propose a novel agent that may bind stronger to PLN than to MMPs. The compound is proposed based on the specific molecular interactions between existing agents and PLN/MMP metalloproteases evaluated by the present molecular simulations. First, we confirmed that the binding energies of PLN agents evaluated using the ab initio fragment molecular orbital method were comparable to the IC50 values obtained through previous experiments. In addition, the specific molecular interactions between these agents and MMP-9 were investigated to elucidate the fact that some of the agents bind weaker to MMP than PLN. Based on the results, we proposed a novel agent having a succinimide group introduce by a hydroxamic acid group and investigated its binding properties with PLN and MMP. The results may provide useful information for the development of potent inhibitors for PLN with few potential side effects in human bodies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Zinco / Simulação de Dinâmica Molecular Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Zinco / Simulação de Dinâmica Molecular Idioma: En Ano de publicação: 2022 Tipo de documento: Article